Renal cancer: Histologic classification update

International Journal of Clinical Oncology

Volumn 3, Issue 3, 1998, Pages 125-133

  Oyasu, Ryoichi ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Classification; Cytogenetic analysis; Morphology; Renal cell carcinoma

Indexed keywords

CHROMOPHOBE ADENOMA; CLEAR CELL CARCINOMA; CYTOGENETICS; DISEASE CLASSIFICATION; EPITHELIUM CELL; GENETIC ANALYSIS; HISTOPATHOLOGY; HUMAN; IMMUNOCYTOCHEMISTRY; KIDNEY CARCINOMA; MOLECULAR GENETICS; PRIORITY JOURNAL; REVIEW;

EID: 0031843360     PISSN: 13419625     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02489903     Document Type: Review

References (82)

1. Furhman SA, Lasky LC, Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 1982;6:655-663.
2. Gelb AB, Shibuya RB, Weiss LM, Medeiros LJ. Stage I renal cell carcinoma. A clinicopathologic study of 82 cases. Am J Surg Pathol 1993;17:275-286.
3. Mancilla-Jimenez R, Stanley RJ. Papillary renal cell carcinoma. A clinical, radiologic and pathologic study of 34 cases. Cancer 1976;38:2469-2480.
4. Thoenes W, Störkel S, Rumpelt HJ. Human chromophobe cell renal carcinoma. Virchows Arch B (Cell Pathol) 1985;48: 207-217.
5. Thoenes W, Störkel S, Rumpelt HJ. Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics. Pathol Res Pract 1986;181:125-143.
6. Fleming S, Lewi HJE. Collecting duct carcinoma of kidney. Histopathology 1986;10:1131-1141.
7. Rumpelt HJ, Störkel S, Moll R, Schärfe T, Thoenes W. Bellini duct carcinoma: further evidence of this rare variant of renal cell carcinoma. Histopathol 1991;18:115-122.
8. Davis CJ, Mostofi FK, Sesterhenn IA. Renal medullary carcinoma. The seventh sickle cell nephropathy. Am J Surg Pathol 1995;19:1-11.
9. Wizigmann-Voos S, Breier G, Risau W, Plate K. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas. Cancer Res 1995;55:1358-1364.
10. Takahashi A, Sasaki H, Kim SJ, Tobisu K, Kakizoe T, Tsukamoto T, Kumamoto Y, Sugimura T, Terada M. Marked increased amounts of messenger RNAs for vascular endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res 1994;54:4233-4237.
11. Fujimoto K, Ichimori Y, Yamaguchi H, Arai K, Futami T, Ozono S, Hirao Y, Kakizoe T, Terada M, Okajima E. Basic fibroblast growth factor as a candidate tumor marker for renal cell carcinoma. Jpn J Cancer Res 1995;86:182-186.
12. Cohen AJ, Li FP, Berg S, Marchetto DJ, Tsai S, Jacobs SC, Brown RS. Hereditary renal-cell carcinoma associated with a chromosomal translocation. New Eng J Med 1979;301:592-595.
13. Kovacs G, Erlandsson R, Boldog F, Ingvarsson S, Müller-Brechlin R, Klein G. Sümegi J. Consistent chromosome 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci USA 1988;85:1571-1575.
14. Kovacs G. Papillary renal cell carcinoma. A morphologic and cytogenetic study of 11 cases. Am J Pathol 1989;134: 27-34.
15. Kovacs G, Kung H-F. Nonhomologous chromatid exchange in hereditary and sporadic renal cell carcinomas. Proc Natl Acad Sci USA 1991;88:194-198.
16. Kovacs G. Molecular differential pathology of renal cell tumors. Histopathology 1993;22:1-8.
17. Goodman MD, Goodman BK, Lubin MB, Braumstein G, Rotter JI, Schreck RR. Cytogenetic characterization of renal cell carcinoma in von Hippel-Lindau syndrome. Cancer 1990;65:1150-1154.
18. Presti GC Jr, Rao PH, Chen Q, Reuter VE, Li FP, Fair WR, Jhanwar SC. Histopathological, cytogenetic and molecular characterization of renal cortical tumors. Cancer Res 1991;51:1544-1552.
19. Pathak S, Strong LC, Ferrell RE, Trindade A. Familial renal cell carcinoma with a 3;11 chromosome translocation limited to tumor cells. Science 1982;217:939-941.
20. Latif F, Tory K, Gnarra J, Yao M, Duh F-M, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L, Schmidt L, Zhou F, Li H, Wei MH, Chen F, Glenn G, Choyke P, Walther MM, Weng Y, Duan D-SR, Dean M, Glavac D, Richards FM, Crossey PA, Ferguson-Smith MA, Le Paslier D, Chumakov I, Cohen D, Chinault AC, Maher ER, Linehan WM, Zbar B, Lerman MI. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 1993;260:1317-1320.
21. Marek RS, Omess PJ, Benson Jr RC, Zinck B. Renal cell carcinoma in von Hippel-Lindau syndrome. Am J Med 1987;82:236-238.
22. Maher ER, Iselius L, Yates JR, Littler M, Benjamin C, Harris R, Sampson J, Williams A, Ferguson-Smith MA, Morton N. Von Hippel-Lindau disease: a genetic study. J Med Genet 1991;28:443-447.
23. Chen F, Kishida T, Yao M, Hustad T, Glavac D, Dean M, Gnarra JG, Orcutt ML, Duh FM, Glenn G, Green J, Hsia E, Lamiell J, Li H,Wei MH, Schmidt L, Tory K, Kuzmin I, Stackhouse Y, Latif F, Linehan M, Lerman MI, Zbar B. Germline mutations in the von Hippel-Lindau disease tumor suppressor gene: correlation with phenotype. Human Mutat 1995;5:66-72.
24. Crossey PA, Richards FM, Foster K, Green JS, Prowse A, Latif F, Lerman MI, Zbar B, Affara NA, Furguson-Smith AF, Maher ER. Identification of intragenic mutation in von Hippel-Lindau disease suppressor gene and correlation with disease phenotype. Human Mol Genet 1994;3:1303-1308.
25. Whaley JM, Naglich J, Gelbert L, Hsia YE, Lamiell JM Green JS, Collins D, Neumann HPH, Laidlaw J, Li FP, Klein-Szanto AJP, Seizinger BR, Kley N. Germ-line mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet 1994;55: 1092-1102.
26. Shuin T, Kondo K, Torigoe S, Kishida T, Kubota Y, Hosaka M, Nagashima Y, Kitamura H, Latif F, Zbar B, Lerman MI, Yao M. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary renal cell carcinoma. Cancer Res 1994;54: 2852-2855.
27. Yao M, Shuin T. Familial renal cell carcinoma: review of recent molecular genetics. Int J Urol 1995;2:61-70.
28. Gnarra JR, Tory K, Weng Y, Schmidt L, Wei MH, Li H, Latif F, Liu S, Chen F, Duh F-M, Lubensky I, Duan DR, Florence C, Pozzatti R, Waether MM, Bander NH, Grossman HB, Brauch H, Pomer S, Brooks JD, Isaacs WB, Lerman MI, Zbar B, Linehan WM. Mutations of the VHL tumor suppressor gene in renal carcinoma. Nature Genet 1994;7:85-90.
29. Herman JG, Latif F, Weng Y, Lerman MI, Zbar B, Liu S, Samid D, Duan D-SR, Gnarr JR, Linehan WM, Baylin SB. Silencing of the VHL tumor suppressor gene by DNA methylation in renal cell carcinoma. Proc Natl Acad Sci USA 1994;91:9700-9704.
30. Krumm A, Groudine M. Tumor suppression and transcription elongation: the dire consequences of changing partners. Science 1995;269:1400-1401.
31. Duan DR, Pause A, Burgers WH, Aso T, Chen DYT, Garret KP, Conaway RC, Conaway JW, Linehan WM, Klausner RD. Inhibition of transcription elongation by the VHL tumor suppressor protein. Science 1995;269:1402-1406.
32. Aso T, Lane WS, Conaway JW, Conaway RC. Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II. Science 1995;269:1439-1443.
33. Gnarra JR, Zhou S, Merril MJ, Wagner JR, Krumm A, Papavassiliou E, Oldfield EH, Klausner RD, Linehan WM. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc Natl Acad Sci USA 1996;93:10589-10594.
34. Iliopoulos O, Levy AP, Jiang C, Kaelin Jr WG, Goldberg MA. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc Natl Acad Sci USA 1996;93:10595-10599.
35. Knebelman B, Ananth S, Cohen HT, Sukhatme VP. Transforming growth factor α is a target for the von Hippel-Lindau tumor suppressor. Cancer Res 1998;58:226-231.
36. Hughson MD, Johnson LD, Silva FG, Kovacs G. Nonpapillary and papillary renal cell carcinoma: a cytogenetic and phenotypic study. Mod Pathol 1993;6:449-456.
37. Ishikawa I, Kovacs G. High incidence of papillary renal cell tumours in patients on chronic hemodialysis. Histopathology 1993;22:135-139.
38. Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS. Papillary (chromophil) renal cell carcinoma. Histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Pathol 1997;21:621-635.
39. Renshaw AA, Corless CL. Papillary renal cell carcinoma. Histology and immunohistochemistry. Am J Surg Pathol 1995;19:842-849.
40. Katter MM, Grignon DJ, Wallis T, Haas GP, Sakr WA, Pontes JE, Visscher DW. Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) renal cell carcinoma. Mod Pathol 1997;10:1143-1150.
41. Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopatholgoic and immunohistochemical study of 105 tumors. Mod Pathol 1997; 0:537-544.
42. Corless CL, Aburatani H, Fletcher JA, Housman D, Amin MB, Weinberg DS. Papillary renal cell carcinoma: Quantitatition of chromosome 7 and 17 by FISH, analysis of 3p for LOH and DNA ploidy. Diag Mol Pathol 1996; 5:53-64.
43. Dal Cin P, Gaeta J, Huben R, Li F, Prout G, Sandberg A. Renal cortical tumors: cytogenetic characterization. Am J Clin Pathol 1989;92:408-414.
44. Schmidt L, Duh F-M, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky I, Dean M, Allikmets R, Chidambaram A, Bergerheim UR, Feltis JT, Casadevall G, Zamarron A, Bernues M, Richard S, Lips CJM, Walther MM, Tsui L-C, Geil L, Orcutt ML, Stackhouse T, Lipan J, Slife L, Branch H, Decker J, Niehaus G, Hughson MD, Moch H, Storkel S, Lerman MI, Linehan WM, Zbar B. Germline and somatic mutations in the tyrosine kinase domain of the MET protooncogene in papillary renal carcinomas. Nature Genet 1997;16:68-73.
45. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 194;122:1450-1459.
46. Zarnegar R, Michalopoulos G. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes. Cancer Res 1989;49: 3314-3320.
47. Matsumoto K, Nakamura T. Emerging multipotent aspect of hepatocyte growth factor. J Biochem 1996;119: 591-600.
48. Di Renzo MF, Narsimhan RP, Olivero M, Bretti S, Giordano S, Medico E, Gaglia P, Zara P, Comoglio PM. Expression of the met/HGF receptor in normal and neoplastic human tissue. Oncogene 1991;6:1997-2003.
49. Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, Aronson S. Identification of hepatocyte growth factor from injured liver of carbon tetrachloride-treated rats. J Biochem 1991;109:8-13.
50. Joseph A, Weiss GH, Jin L, Fuchs A, Chowdhury S, Goldberg ID, Rosen EM. Expression of scatter factor in bladder cancer. J Natl Cancer Inst 1995;87:372-377.
51. Zbar B, Glenn G, Lubensky I, Choyke P, Walther MM, Magnusson G, Bergerheim USR, Patterson S, Amin M, Hurley K, Linehan WM. Hereditary papillary renal cell carcinoma: clinical studies in 10 families. J Urol 1995;153:907-912.
52. Meloni AM, Dobbs RM, Pontes JE, Sandberg AA. Translocation [X;1] in papillary renal adenocarcinoma. A new cytogenetic subtype. Cancer Genet Cytogenet 1993;65:1-6.
53. Bonsib SM, Lager DJ. Chromophobe cell carcinoma: analysis of five cases. Am J Surg Pathol 1990;14:260-267.
54. Aktar M, Kardar H, Linjawi T, McClintock J, Ali MA. Chromphobe cell carcinoma of the kidney. A clinicopathologic study of 21 cases. Am J Surg Pathol 1995;19:1245-1256.
55. Storkel S, Steart PV, Drenckhahn D, Thoenes W. The human chromophobe cell renal carcinoma: its probable relation to intercalated cells of the collecting duct. Virchows Archiv B Cell Pathol 1989;56:237-245.
56. Tickoo SF, Amin MB, Zarbo RJ. Colloidal iron staining in renal epithelial neoplasms, including chromophobe renal cell carcinoma. Am J Surg Pathol 1998;22:419-424.
57. Crotty TB, Farrow GM, Lieber MM. Chromophobe cell renal carcinoma: clinicopathologic features of 50 cases. J Urol 1995;154:964-967.
58. Renshaw AA, Henske EP, Loughlin KR, Shapiro C, Weinberg DS. Aggressive variants of chromophobe renal cell carcinoma. Cancer 1996;78:1756-1761.
59. Schwerdtle RF, Störkel S, Neuhaus C, Brauch H, Weidt E, Brenner W, Hohenfellner R, Huber C, Decker H-J. Allelic losses at chromosomes 1p, 2p, 6p, 10p, 13q, 17p and 21q significantly correlate with the chromophobe subtype of renal cell carcinoma. Cancer Res 1996;56:2927-2930.
60. Bugert P, Gaul C, Weberk, Herbers J, Aktar M, Ljungberg B, Kovacs G. Specific genetic changes of diagnostic importance in chromophobe renal cell carcinoma. Lab Invest 1997;76:203-208.
61. Speicher MR, Schoell B, du Manoir S, Schröck E, Ried T, Cremer T, Störkel T, Kovacs A, Kovacs G. Specific loss of chromosomes 1, 2, 6, 10, 13, 17 and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridization. Am J Pathol 1994;145:356-364.
62. Aizawa S, Kikuchi Y, Suzuki M, Furusato M. Renal cell carcinoma of lower nephron origin. Acta Pathol Jpn 1987;37: 567-574.
63. Baer SC, Ro JY, Ordonez NG, Maiese RL, Loose JH, Grignon DG, Ayala AG. Sarcomatoid collecting duct carcinoma. A clinicopathologic and immunohistochemical study of five cases. Human Pathol 1993;24:1017-1022.
64. Abrahams JH, Drachenberg M, Beckwith JB. Medullary renal carcinoma (MRC): a report of 28 new cases. Mod Pathol 1998;11:74A.
65. Avery RA, Harris JE, Davis CJ, Borgaonkar DS, Byrd JC, Weiss RB. Renal medullary carcinoma. Clinical and therapeutic aspects of a newly described tumor. Cancer 1996;78:128-132.
66. Polascik TJ, Cairns P, Epstein JI, Fuzesi L, Ro JY, Marshall FF, Sidransky D, Schoenberg M. Distal nephron renal tumors: microsattelite allelotype. Cancer Res 1996;56: 1892-1895.
67. Steiner G, Cairns P, Polascick TJ, Marshall FF, Epstein JI, Sidransky D, Schoenberg M. High-density mapping of chromosomal arm 1q in renal collecting duct carcinoma: region of minimal deletion at 1q 32.1-32.2. Cancer Res 1996;56:5044-5046.
68. Klein MJ, Valensi QJ. Proximal tubular adenomas of kidney with so-called oncocytic features. A clinicopathologic study of 13 cases of a rarely reported neoplasm. Cancer 1976;38:906-914.
69. Lieber NM, Tomera KM, Farrow GM. Renal oncocytoma. J Urol 1981;125:481-485.
70. Davis CJ Jr, Sesterhenn IA, Mostofi FK, Ho CK. Renal oncocytoma. Clinico-pathological study of 166 patients. J Urogenit Pathol 1991;1:41-52.
71. Perez-Ordonez B, Hamed G, Campbell S, Erlandson RA, Russo P, Gaudin PB, Reuter VE. Renal oncocytoma: a clinicopathologic study of 70 cases. Am J Surg Pathol 1997;21: 871-883.
72. Amin MB, Crotty TB, Tickoo SK, Farrow GM. Renal oncocytoma: a reappraisal of morphologic features with clinicopathologic findings in 80 cases. Am J Surg Pathol 1997;21:1-12.
73. Brauch H, Tory K, Linehan WM, Weaver DJ, Lovell MA, Zbar B. Molecular analysis of the short arm of chromosome 3 in five renal oncocytomas. J Urol 1990;143:622-624.
74. Brown JA, Takahashi S, Alcaraz A, Borell TJ, Anderl KL, Qian J, Persons DL, Bostwick DG, Lieber MM, Jenkins RB. Fluorescence in situ hybridization analysis of renal oncocytoma reveals frequent loss of chromosomes Y and 1. J Urol 1996;156:31-35.
75. Neuhaus C, Dijkhuizen T, vanden Berg E, Störkel S, Stöckel M, Mensch B, Huber C, Decker H-J. Involvement of the chromosomal region 11q13 in renal oncocytoma: case report and literature review. Cancer Genet Cytogenet 1997;94:95-98.
76. Ro JY, Ayala AG, Sella A, Samuels ML, Swanson DA. Sarcomatoid renal cell carcinoma: clinicopathologic. A study of 42 cases. Cancer 1987;59:516-526.
77. Medeiros LJ, Gelb AB, Weiss LM. Renal cell carcinoma. Prognostic significance of morphologic parameters in 121 cases. Cancer 1988;56:503-508.
78. DeLong W, Grignon DJ, Eberwein P, Shum DT, Wyatt JK. Sarcomatoid renal cell carcinoma. An immunohistochemical study of 18 cases. Arch Pathol Lab Med 1993;117:634-640.
79. Bonsib SM, Fischer J, Plattner S, Fallon B. Sarcomatoid renal tumors. Clinicopathologic correlation of three cases. Cancer 1987;59:527-532.
80. Deitchman B, Sidhu G. Ultrastructural study of a sarcomatoid variant of renal cell carcinoma. Cancer 1980;46:1152-1157.
81. Tomera KM, Farrow GM, Lieber MM. Sarcomatoid renal carcinoma. J Urol 1983;30:657-659.
82. Santoro M, Carlomagno F, Romano A, Bottaro DP, Dathan NA, Grieco M, Fusco A, Vecchio G, Matoskova B, Kraus MH, Di Fiore PP. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 1995;267:381-383.